Business·Industry

"We Will Reduce Reliance on Chinese Materials Amid Tighter U.S. Tax Credit Requirements" - LG Corp. Conference Call

JAEMIN SONG
2026-11-03 10:29:18
[Edaily Reporter JAEMIN SONG ] “To qualify for tax credits in the U.S., companies must meet the material content requirements for prohibited foreign entities (PFEs) in direct material costs. The permitted percentage is set to decrease from 40% this year to 35% or less next year, so we are preparing procurement strategies for each material to meet this requirement.

For cathode materials, we have secured a plan to source from multiple non-PFE suppliers in addition to the domestic company with which we recently signed a contract. We are also identifying additional suppliers for key materials such as anode materials, separators, and electrolytes.

“Going forward, we will strengthen supply chain stability by considering not only cost competitiveness but also global policies and geopolitical risks, while expanding our efforts to identify local partners and advance localization.”

…LG Energy Solution Q3 2026 Conference Call

LG Energy Solution’s Wrocław plant in Poland. (Photo: LG Energy Solution)

Economy

Corporation

IT·Science

Economy

"Strengthening Local Production in Europe… Expectations for Growing Demand for Non-Chinese Batteries" - LG Corp. Conference Call

"Although the policy direction in Europe has not yet been finalized, according to the IAA’s proposed amendments, foreign direct investment and localization requirements are expected to be further stre…
2026-11-03 10:59:17

Corporation

"ESS Order Backlog Reaches 160 GWh… First Direct Supply Contract Signed with a Big Tech Company" - LG Corp. Conference Call

"In the ESS business, the company has strengthened its market position in the AI data center sector by securing additional projects from existing utility grid customers and, for the first time, signin…
2026-11-03 10:17:55

IT·Science

LGCHEM,LTD Expands Technology Export Agreement for New Drug to Treat Rare Obesity to 1.15 Trillion

LGCHEM,LTD(051910)has expanded the value of its technology export agreement with U.S.-based Rhythm Pharmaceuticals for the rare obesity treatment “Vivamelagon” from the original $305 million (approxim…
2026-11-03 11:21:02